Jeffrey R McLaughlin1, Kyla R Lee2. 1. The Kennedy Center, Mercy Medical Center, Oshkosh, Wisconsin. 2. Gundersen Lutheran Medical Center, LaCrosse, Wisconsin.
Abstract
BACKGROUND: Previously, we reported the mean 16-year results of primary uncemented total hip arthroplasty using a tapered femoral component in patients <50 years. The purpose of this study was to update our previous report using the Taperloc femoral component in young patients who had been followed for a minimum of 20 years postoperatively. METHODS: Between 1983 and 1990, 108 consecutive uncemented total hip arthroplasties were performed in 91 patients of age <50 years, with use of the Taperloc femoral component. Every patient was followed for a minimum of 20 years after surgery or until death. At a mean of 25 (range, 20-29 years) postoperatively, 76 patients (91 hips) were living. The Harris Hip Score, radiographic results, complications, and Kaplan-Meier survivorship were evaluated. RESULTS: In the entire cohort of 108 hips, 9 femoral components (8%) have been revised, none for aseptic loosening. Five well-fixed stems were removed during acetabular revision, 3 stems were revised for infection, and 1 stem was exchanged because of a peroneal nerve palsy. Distal femoral osteolysis was identified around 1 hip. With failure defined as stem removal for any reason, implant survival was 90% (CI = 82-95) at 29 years. With failure defined as stem removal for aseptic loosening, implant survival was 100% at 29 years. CONCLUSION: Primary total hip arthroplasty with the Taperloc femoral component in young patients was associated with a high rate of survival at 29 years.
BACKGROUND: Previously, we reported the mean 16-year results of primary uncemented total hip arthroplasty using a tapered femoral component in patients <50 years. The purpose of this study was to update our previous report using the Taperloc femoral component in young patients who had been followed for a minimum of 20 years postoperatively. METHODS: Between 1983 and 1990, 108 consecutive uncemented total hip arthroplasties were performed in 91 patients of age <50 years, with use of the Taperloc femoral component. Every patient was followed for a minimum of 20 years after surgery or until death. At a mean of 25 (range, 20-29 years) postoperatively, 76 patients (91 hips) were living. The Harris Hip Score, radiographic results, complications, and Kaplan-Meier survivorship were evaluated. RESULTS: In the entire cohort of 108 hips, 9 femoral components (8%) have been revised, none for aseptic loosening. Five well-fixed stems were removed during acetabular revision, 3 stems were revised for infection, and 1 stem was exchanged because of a peroneal nerve palsy. Distal femoral osteolysis was identified around 1 hip. With failure defined as stem removal for any reason, implant survival was 90% (CI = 82-95) at 29 years. With failure defined as stem removal for aseptic loosening, implant survival was 100% at 29 years. CONCLUSION: Primary total hip arthroplasty with the Taperloc femoral component in young patients was associated with a high rate of survival at 29 years.
Authors: Francesco Pogliacomi; Paolo Schiavi; Guido Grappiolo; Francesco Ceccarelli; Enrico Vaienti Journal: Int Orthop Date: 2019-04-24 Impact factor: 3.075
Authors: Thilo Floerkemeier; Stefan Budde; Nils Wirries; Gabriela von Lewinski; Henning Windhagen; Marco Ezechieli Journal: Int Orthop Date: 2017-08-17 Impact factor: 3.075
Authors: Fernando Díaz-Dilernia; Agustín M García-Mansilla; Agustín Albani-Forneris; Pablo A Slullitel; Gerardo Zanotti; Fernando Comba; Francisco Piccaluga; Martin Buttaro Journal: Eur J Orthop Surg Traumatol Date: 2021-06-12
Authors: Marcus R Streit; Burkhard Lehner; David S Peitgen; Moritz M Innmann; Georg W Omlor; Tilman Walker; Christian Merle; Babak Moradi Journal: Clin Orthop Relat Res Date: 2020-06 Impact factor: 4.755
Authors: Felipe Spinelli Bessa; Ronald Delgadillo Fuentes; Helder de Souza Miyahara; Alberto Tesconi Croci; Leandro Ejnisman; José Ricardo Negreiros Vicente Journal: Rev Bras Ortop Date: 2018-10-10